[Public Notice+] Mediforum Pharmaceutical to Propose Board Size Adjustment and Auditor Dismissal at Extraordinary General Meeting

[Asia Economy Reporter Minwoo Lee] Mediforum Pharmaceutical, recently incorporated into the HL Biopharma Group, is increasing the number of directors and dismissing the auditor.

Mediforum Pharmaceutical announced on the 4th that it will hold an extraordinary general meeting of shareholders on the 16th of next month.

At this extraordinary general meeting, resolutions will be made regarding ▲increasing the number of directors ▲dismissal of the auditor ▲approval of stock option grants, among others. If these proposals are approved, the number of directors will increase from the current 5 to 9. Two agenda items, including partial amendments to the articles of incorporation such as company name change and director appointments, will be finalized later.

Meanwhile, Mediforum Pharmaceutical recently changed its largest shareholder to HL Biopharma Group. The final procedures will be completed once the capital increase amount is paid on the 14th.

This content was produced with the assistance of AI translation services.